Sellier P, Corona P, Prunier L, Duong T C, Audouin P
Service de rééducation cardiaque, hôpital Broussais, Paris.
Arch Mal Coeur Vaiss. 1993 Jun;86 Spec No 3:19-23.
Silent myocardial ischaemia (SMI) is a common manifestation of coronary artery disease. Continuous electrocardiographic recordings have shown that 75% of ischemic episodes are asymptomatic. In addition, SMI has the same consequences as symptomatic ischaemia on myocardial perfusion and ventricular function. There are many means of detecting SMI, continuous electrocardiographic monitoring, exercise stress testing with or without methods of analysis of myocardial perfusion or wall motion using radioactive tracers or echocardiography. The latter techniques seem to improve the sensitivity of exercise stress testing. More recently, pharmacological stress testing coupled with myocardial scintigraphy or echocardiography has been introduced. In coronary patients, the prevalence of SMI on Holter monitoring is about 50% in angina and 25% after myocardial infarction. The prognostic value of SMI has been the object of much research. In asymptomatic patients with documented coronary artery disease, SMI is associated with a relative risk of a cardiac event 2 to 3 times greater than that of subjects without ischaemia. In angina pectoris, the relative risk of future cardiac events is 5.3 times greater, and that of death is 2.3 times greater. These results reported with the Holter method have been confirmed by those of exercise stress testing with and without coupled imaging techniques. In unstable angina, the results are the same: the relative risk of cardiac events in patients with SMI on Holter monitoring is increased by a factor of 4.5, and that of death by a factor of 4. This increased risk is also observed after myocardial infarction whether SMI is recorded by Holter monitoring or exercise stress testing. However, these observations are not confirmed in all reports.(ABSTRACT TRUNCATED AT 250 WORDS)
无症状性心肌缺血(SMI)是冠状动脉疾病的常见表现。连续心电图记录显示,75%的缺血发作是无症状的。此外,SMI在心肌灌注和心室功能方面与有症状的缺血具有相同的后果。检测SMI有多种方法,包括连续心电图监测、运动负荷试验,运动负荷试验可结合或不结合使用放射性示踪剂或超声心动图分析心肌灌注或壁运动的方法。后一种技术似乎提高了运动负荷试验的敏感性。最近,已引入了结合心肌闪烁显像或超声心动图的药物负荷试验。在冠心病患者中,动态心电图监测显示的SMI患病率在心绞痛患者中约为50%,在心肌梗死后为25%。SMI的预后价值一直是许多研究的对象。在有冠状动脉疾病记录的无症状患者中,SMI与心脏事件的相对风险比无缺血的受试者高2至3倍。在心绞痛患者中,未来心脏事件的相对风险高5.3倍,死亡风险高2.3倍。动态心电图方法报告的这些结果已通过有或无联合成像技术的运动负荷试验结果得到证实。在不稳定型心绞痛中,结果相同:动态心电图监测显示有SMI的患者发生心脏事件的相对风险增加4.5倍,死亡风险增加4倍。无论动态心电图监测还是运动负荷试验记录到SMI,心肌梗死后也观察到这种风险增加。然而,并非所有报告都证实了这些观察结果。(摘要截断于250字)